HspE7
id:
hspe7-272-139888
title:
HspE7
text:
HspE7 is an investigational therapeutic vaccine candidate being developed by Nventa Biopharmaceuticals for the treatment of precancerous and cancerous lesions caused by the human papillomavirus (HPV). HspE7 uses recombinant DNA technology to covalently fuse a heat shock protein (Hsp) to a target antigen, thereby stimulating cellular immune system responses to specific diseases. HspE7 is a patented construct consisting of the HPV Type 16 E7 protein and heat shock protein 65 (Hsp65) and is current
brand slug:
wiki
category slug:
encyclopedia
description:
Investigational HPV vaccine
original url:
https://en.wikipedia.org/wiki/HspE7
date created:
date modified:
2023-12-27T10:01:34Z
main entity:
{"identifier":"Q17151936","url":"https://www.wikidata.org/entity/Q17151936"}
image:
fields total:
13
integrity:
14